2-Ethyl-4,5-dimethylthiazole
Common Name: |
2-Ethyl-4,5-dimethylthiazole |
IUPAC Name: |
2-ethyl-4,5-dimethyl-1,3-thiazole |
Molecular Formula: |
C6H10O3 |
SMILES: |
CCC1=NC(=C(S1)C)C |
Inchi: |
1S/C7H11NS/c1-4-7-8-5(2)6(3)9-7/h4H2,1-3H3 |
Inchi Key: |
BVOKJOZBJOWZNJ-UHFFFAOYSA-N |
Cas No: |
873-64-3 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
3 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
130.14 |
Mass (g/mol) |
141.061 |
Molar Refractivity |
32.44 |
Net Charge |
|
HBD |
|
HBA |
3 |
Rt Bonds |
4 |
Rings |
1 |
TPSA |
43.37 |
Hetero Atoms |
2 |
Heavy Atoms |
9 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
104.00 |
Boiling Point (°C@760.00mm Hg) |
185.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.402 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.67 |
LogP |
2.322 |
iLOGP |
1.76 |
XLOGP3 |
0.89 |
WLOGP |
0.53 |
MLOGP |
0.28 |
ESOL Log S |
-0.94 |
ESOL Solubility (mg/ml) |
14.8 |
ESOL Solubility (mol/l) |
0.114 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.39 |
Ali Solubility (mg/ml) |
5.36 |
Ali Solubility (mol/l) |
0.04 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-1.06 |
Silicos-IT Solubility (mg/ml) |
11.2 |
Silicos-IT Solubility (mol/l) |
0.09 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.46 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.72 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.34 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |